Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study
by Miguel Garcia-Knight, Khamal Anglin, Michel Tassetto, Scott Lu, Amethyst Zhang, Sarah A. Goldberg, Adam Catching, Michelle C. Davidson, Joshua R. Shak, Mariela Romero, Jesus Pineda-Ramirez, Ruth Diaz-Sanchez, Paulina Rugart, Kevin Donohue, Jonathan Massachi, Hannah M. Sans, Manuella Djomaleu, Sujata Mathur, Venice Servellita, David McIlwain, Brice Gaudiliere, Jessica Chen, Enrique O. Martinez, Jacqueline M. Tavs, Grace Bronstone, Jacob Weiss, John T. Watson, Melissa Briggs-Hagen, Glen R. Abedi, George W. Rutherford, Steven G. Deeks, Charles Chiu, Sharon Saydah, Michael J. Peluso, Claire M. Midgley, Jeffrey N. Martin, Raul Andino, J. Daniel Kelly
The impact of vaccination on SARS-CoV-2 infectiousness is not well understood. We compared longitudinal viral shedding dynamics in unvaccinated and fully vaccinated adults. SARS-CoV-2-infected adults were enrolled within 5 days of symptom onset and nasal specimens were self-collected daily for two weeks and intermittently for an additional two weeks. SARS-CoV-2 RNA load and infectious virus were analyzed relative to symptom onset stratified by vaccination status. We tested 1080 nasal specimens from 52 unvaccinated adults enrolled in the pre-Delta period and 32 fully vaccinated adults with predominantly Delta infections. While we observed no differences by vaccination status in maximum RNA levels, maximum infectious titers and the median duration of viral RNA shedding, the rate of decay from the maximum RNA load was faster among vaccinated; maximum infectious titers and maximum RNA levels were highly correlated. Furthermore, amongst participants with infectious virus, median duration of infectious virus detection was reduced from 7.5 days (IQR: 6.0–9.0) in unvaccinated participants to 6 days (IQR: 5.0–8.0) in those vaccinated (P = 0.02). Accordingly, the odds of shedding infectious virus from days 6 to 12 post-onset were lower among vaccinated participants than unvaccinated participants (OR 0.42 95% CI 0.19–0.89). These results indicate that vaccination had reduced the probability of shedding infectious virus after 5 days from symptom onset.